FI782442A - Stelnad farmaceutisk foerening innehaollande cellvaeggsmaterial - Google Patents

Stelnad farmaceutisk foerening innehaollande cellvaeggsmaterial

Info

Publication number
FI782442A
FI782442A FI782442A FI782442A FI782442A FI 782442 A FI782442 A FI 782442A FI 782442 A FI782442 A FI 782442A FI 782442 A FI782442 A FI 782442A FI 782442 A FI782442 A FI 782442A
Authority
FI
Finland
Prior art keywords
cellvaeggsmaterial
foerening
innehaollande
pharmaceutical
steel
Prior art date
Application number
FI782442A
Other languages
English (en)
Other versions
FI65370B (fi
FI65370C (fi
Inventor
Yuichi Yamamura
Ichiro Azuma
Katsusuke Ennyu
Osamu Aoki
Original Assignee
Yuichi Yamamura
Ichiro Azuma
Katsusuke Ennyu
Osamu Aoki
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yuichi Yamamura, Ichiro Azuma, Katsusuke Ennyu, Osamu Aoki filed Critical Yuichi Yamamura
Publication of FI782442A publication Critical patent/FI782442A/fi
Publication of FI65370B publication Critical patent/FI65370B/fi
Application granted granted Critical
Publication of FI65370C publication Critical patent/FI65370C/fi

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55583Polysaccharides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588Adjuvants of undefined constitution
    • A61K2039/55594Adjuvants of undefined constitution from bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FI782442A 1977-08-09 1978-08-09 Foerfarande foer framstaellning av ett fast farmaceutiskt preparat FI65370C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same
JP9587177 1977-08-09

Publications (3)

Publication Number Publication Date
FI782442A true FI782442A (fi) 1979-02-10
FI65370B FI65370B (fi) 1984-01-31
FI65370C FI65370C (fi) 1984-05-10

Family

ID=14149407

Family Applications (1)

Application Number Title Priority Date Filing Date
FI782442A FI65370C (fi) 1977-08-09 1978-08-09 Foerfarande foer framstaellning av ett fast farmaceutiskt preparat

Country Status (15)

Country Link
US (1) US4543253A (fi)
JP (1) JPS5428813A (fi)
AU (1) AU526788B2 (fi)
BE (1) BE869610A (fi)
CA (1) CA1118348A (fi)
CH (1) CH643459A5 (fi)
DE (1) DE2834893A1 (fi)
DK (1) DK153443C (fi)
FI (1) FI65370C (fi)
FR (1) FR2399844A1 (fi)
GB (1) GB2002229B (fi)
HU (1) HU179726B (fi)
IT (1) IT1098381B (fi)
NL (1) NL7808337A (fi)
SE (1) SE447629B (fi)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DD273198A5 (de) * 1986-06-09 1989-11-08 �������@�������k���Kk�� Verfahren zur herstellung eines modifikationsmittels
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
JP4447779B2 (ja) * 1998-07-16 2010-04-07 市郎 東 細菌の菌体成分を有効成分とする癌免疫療法用製剤
WO2004012751A1 (ja) * 2002-08-02 2004-02-12 Sumitomo Pharmaceuticals Company, Limited 細菌細胞壁骨格成分製剤
CA2564180A1 (en) * 2004-04-22 2005-11-03 Dainippon Sumitomo Pharma Co., Ltd. Pharmaceutical preparation containing bacterial cell wall skeleton component
CN115300490B (zh) * 2021-05-07 2024-04-16 安徽远望乐桓药业有限公司 包含角鲨烯和甘露醇的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185623A (en) * 1960-05-31 1965-05-25 Smith Fred Preservation of animal semen
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
FR2268531B1 (fi) * 1974-04-25 1978-07-21 Anvar
DE2527636A1 (de) * 1974-06-20 1976-01-08 Anvar Verfahren zur herstellung von mycobakteriellen fraktionen
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation

Also Published As

Publication number Publication date
GB2002229B (en) 1982-05-26
AU526788B2 (en) 1983-02-03
SE447629B (sv) 1986-12-01
DK153443C (da) 1988-12-05
SE7808414L (sv) 1979-02-10
GB2002229A (en) 1979-02-21
US4543253A (en) 1985-09-24
FR2399844A1 (fr) 1979-03-09
FR2399844B1 (fi) 1982-08-20
JPS631291B2 (fi) 1988-01-12
HU179726B (en) 1982-11-29
FI65370B (fi) 1984-01-31
AU3879178A (en) 1980-02-14
DK352578A (da) 1979-02-10
BE869610A (fr) 1979-02-08
CA1118348A (en) 1982-02-16
IT7826609A0 (it) 1978-08-08
FI65370C (fi) 1984-05-10
CH643459A5 (de) 1984-06-15
NL7808337A (nl) 1979-02-13
DE2834893C2 (fi) 1987-08-27
DK153443B (da) 1988-07-18
DE2834893A1 (de) 1979-02-22
JPS5428813A (en) 1979-03-03
IT1098381B (it) 1985-09-07

Similar Documents

Publication Publication Date Title
DK137878A (da) Tabletopbygning
SE7803475L (sv) Hallare for pasar
SE7803476L (sv) Hallare for pasar
SE7807569L (sv) Sandwichkonstruktion
SE7712754L (sv) Bervegg for rorslingor
SE7809373L (sv) Farmaceutiskt anvendbara 5-hydroxi-1h-imidazol-4-karboxamidderivat
IT1095377B (it) Composizione farmaceutica
SE7812411L (sv) Instas for eldstad
TR21418A (tr) Akarisid maddeler
FI782442A (fi) Stelnad farmaceutisk foerening innehaollande cellvaeggsmaterial
FI780463A (fi) Tablettkross
SE7806441L (sv) Lekemedelskomposition
FI54737B (fi) Med friktionsplanethjul foersedd vaexel
FI780216A (fi) Anordning foer faergtelevisionsmottagare
DK209078A (da) Staaledel
AT385853B (de) Winkelgeschwindigkeitsmesser
FI772008A (fi) Ramsaog med massutjaemningsanordning
ATA645377A (de) Drehkreuz
FI781507A (fi) Farmaceutiska kompositioner
FI65345B (fi) Antennvaegguttag med en koppformad uttagskropp
SE7813062L (sv) Farmaceutisk komposition
IT7867673A0 (it) Medicamento normolipidemizzante
DK125778A (da) Fungcide midler
SE7803559L (sv) Korrosionsbestendigt cr-ni-mo-stal
SE7707875L (sv) Hallare for hyvelsker

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: ENNYU, KATSUSUKE

Owner name: AZUMA, ICHIRO

Owner name: AOKI, OSAMU

Owner name: YAMAMURA, YUICHI